Osel Devices Limited, a company that operates in the technology-driven manufacturing sector, has already made its debut on the stock market through an initial public offering (IPO). This SME IPO generated interest, particularly for those looking to diversify their portfolio within the electronics and healthcare equipment industries. By going public, Osel Devices aimed to raise capital for future growth and enhance its foothold in both domestic and international markets.
In this blog, we provide details of the Osel Devices Limited IPO and discuss whether it’s a wise IPO investment.
Type of issue | Book built issue IPO |
Issue size | 4,416,000 shares (aggregating up to ₹70.66 Cr) |
Fresh issue | 4,416,000 shares (aggregating up to ₹70.66 Cr) |
Offer period | September 16, 2024 - September 19, 2024 |
Basis of allotment | September 20, 2024 |
Initiation of refunds | September 23, 2024 |
Osel Devices IPO date of listing | September 24, 2024 |
Osel Devices IPO price band | ₹155 to ₹160 per share |
Credit of shares to demat | September 23, 2024 |
Minimum lot size | 1 lot (800 shares) amounting to ₹128,000 |
Founded in 2006, Osel Devices Limited, formerly known as Innovative Infratech Solutions Private Limited, has become a notable player in the manufacturing of LED display systems and hearing aids. The company's comprehensive LED display systems serve a variety of purposes, including advertising media, billboards, corporate boardrooms, and command centres.
In addition to their LED displays, Osel Devices also manufactures hearing aids, which are designed to assist individuals with hearing impairments. The company's hearing aids, commonly referred to as health aids, are available in both digitally programmable and non-programmable versions.
Metric | Value |
Revenue growth (FY2023 vs FY2024) | 62% |
Profit After Tax (PAT) growth (FY2023 vs FY2024) | 180% |
Investing in the Osel Devices Limited IPO presents both opportunities and risks. On the one hand, the company’s diversification across the LED display and healthcare sectors, along with its technological innovation, provides the potential for growth. Moreover, the SME market segment often offers room for faster expansion, making it attractive for investors looking for high-growth stocks.
On the other hand, the competitive landscape, dependence on key clients, and operational risks pose notable challenges for the upcoming IPO. Additionally, as an SME IPO, liquidity could be limited compared to larger offerings.
For investors with an increased risk tolerance and an interest in niche markets, Osel Devices Limited's IPO could be a worthwhile consideration, particularly given the growth potential in both the commercial and healthcare sectors. However, it’s important to carefully evaluate the company’s financials and industry competition before making any decisions.
Osel Devices Limited’s IPO represents a chance for investors to participate in a company that is diversified across the commercial and healthcare markets. While the company has several strengths, such as a broad product portfolio and technological innovation, it also faces challenges that warrant caution. Investors should know the potential risks and rewards carefully to determine whether this IPO aligns with their investment strategy and risk appetite.
The minimum lot size for the Osel Devices Limited IPO is 800 shares.
The grey market premium (GMP) for Osel Devices Limited IPO is ₹110.
The IPO is expected to open on September 16, 2024.